Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Συνδρομές Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Ενδείξεις και αγωγές Βρείτε θεραπευτικές ενδείξεις και αγωγές για νόσους, συμπτώματα και ιατρικές πράξεις
Γνωρίζατε ότι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα

DEXSOL Oral solution (2022)

Αναφορές

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Περιεχόμενα

Name of the medicinal product

Dexsol 2mg/5ml Oral Solution.

Qualitative and quantitative composition

Dexamethasone 2mg/5ml (as dexamethasone sodium phosphate). Excipients: Propylene glycol (E1520) – 450.6mg/5ml Liquid maltitol (E965) - 1375mg/5ml Sorbitol, liquid (non-crystallising) (E420) - 700mg/5ml ...

Pharmaceutical form

Oral Solution. A colourless to faint yellow solution with odour of mint.

Therapeutic indications

Dexamethasone is a corticosteroid. It is designed for use in certain endocrine and non-endocrine disorders, in certain cases of cerebral oedema and for diagnostic testing of adrenocortical hyperfunction. ...

Posology and method of administration

Posology Adults General considerations The dosage should be titrated to the individual response and the nature of the disease. In order to minimise side effects, the lowest effective possible dosage should ...

Contraindications

Hypersensitivity to dexamethasone or any of the excipients listed in section 6.1. Systemic infection unless specific anti*infective therapy is employed. Systemic fungal infections. Stomach ulcer or duodenal ...

Special warnings and precautions for use

<b>A patient information leaflet should be supplied with this product.</b> Patients should carry steroid treatment cards, which give clear guidance on the precautions to be taken to minimise risk, and ...

Interaction with other medicinal products and other forms of interaction

Effects of other medicinal products on dexamethasone: Dexamethasone is metabolized via cytochrome P450 3A4 (CYP3A4). Concomitant administration of dexamethasone with inducers of CYP3A4, such as phenytoin, ...

Pregnancy and lactation

Since adequate human reproduction studies have not been performed with corticosteroids, dexamethasone should not be used during pregnancy for maternal indications, unless it is clearly necessary. The lowest ...

Effects on ability to drive and use machines

There are some side effects associated with this product that may affect some patients' ability to drive or operate machinery (see 4.8 Undesirable effects).

Undesirable effects

The incidence of predictable undesirable effects, including hypothalamic-pituitary-adrenal suppression correlates with the relative potency of the drug, dosage, timing of administration and the duration ...

Overdose

Reports of acute toxicity and/or deaths following overdosage with glucocorticoids are rare. No antidote is available. Treatment is probably not indicated for reactions due to chronic poisoning unless the ...

Pharmacodynamic properties

<b>Pharmacotherapeutic Group:</b> Corticosteroid <b>ATC Code:</b> H02AB02 Dexamethasone is a highly potent and long-acting glucocorticoid with negligible sodium retaining properties and is therefore, particularly ...

Pharmacokinetic properties

Dexamethasone is well absorbed when given by mouth; peak plasma levels are reached between 1 and 2 hours after ingestion and show wide interindividual variations. The mean plasma half life is 3.6 ± 0.9h. ...

Preclinical safety data

In animal studies, cleft palate was observed in rats, mice, hamsters, rabbits, dogs and primates; not in horses and sheep. In some cases these divergences were combined with defects of the central nervous ...

List of excipients

Benzoic acid (E420) Propylene glycol (E1520) Citric acid monohydrate Liquid maltitol (E965) Garden mint flavour (containing isopropanol and propylene glycol (E1520)) Liquid sorbitol (non-crystallising) ...

Incompatibilities

Not applicable.

Shelf life

2 years. Shelf life after first opening the container: 3 months.

Special precautions for storage

Do not store above 25°C. Do not refrigerate. The storage at temperatures higher than 25°C could allow precipitation inside the solution. Do not use the product if solid particles are observed inside the ...

Nature and contents of container

<u>Bottles:</u> 75ml and 150ml in Amber (Type III) glass. <u>Closures:</u> HDPE, EPE wadded, tamper evident, child resistant closure.

Special precautions for disposal and other handling

No special requirement for disposal. Instructions for administration via nasogastric (NG) or percutaneous endoscopic gastrostomy (PEG) tubes. Dexsol Oral Solution is suitable for use with the following ...

Marketing authorization holder

Rosemont Pharmaceuticals Ltd., Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, UK

Marketing authorization number(s)

PL 00427/0137

Date of first authorization / renewal of the authorization

8<sup>th</sup> March 2005

Date of revision of the text

18<sup>th</sup> January 2022

Πηγαίο έγγραφο

Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:

Μπορείτε να υποστηρίξετε τον Γαληνό στην αποστολή του να παρέχει δωρεάν έγκυρη πληροφόρηση για κάθε φάρμακο απενεργοποιώντας το Ad Blocker για αυτόν τον ιστότοπο.